Join
Live feed
·
INSIDERFilingvia Quantisnow
Edgewise Therapeutics Inc. logo

Chief Business Officer Derakhshan Behrad converted options into 5,209 shares and sold $27,824 worth of shares (1,691 units at $16.45), increasing direct ownership by 21% to 20,355 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EWTX (Edgewise Therapeutics Inc.) and more on Quantisnow.